Juan Zhang

Dr. Juan Zhang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2023 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
YWYa-Sen Wang
Ya-Sen Wang
WSWei Shen
Wei Shen
QYQing Yang
Qing Yang
RLRong Lin
Rong Lin
LTLi-Xia Tang
Li-Xia Tang
XLXin-Zhu Lin
Xin-Zhu Lin
Background: It is proposed that the development of parenteral nutrition-associated cholestasis (PNAC) was significantly associated with preterm birth, low birth weight, infection, etc.; however, the etiology and pathogenesis of PNAC are not fully understood. Most of the studies examining PNAC-associated risk factors were single-center studies with relatively small sample sizes. Objective: To analyze the risk factors associated with PNAC in preterm infants in China. Methods: This is a retrospective multicenter observational study. Clinical data on the effect of multiple oil-fat emulsions (soybean oil-medium chain triglycerides-olive oil-fish oil, SMOF) in preterm infants were collected from a prospective multicenter randomized controlled study. A secondary analysis was performed in which preterm infants were divided into the PNAC group and the non-PNAC group based on the PNAC status. Results: A total of 465 cases very preterm infants or very low birth weight infants were included in the study in which 81 cases were assigned to the PNAC group and 384 cases were assigned to the non-PNAC group. The PNAC group had a lower mean gestational age, lower mean birth weight, longer duration of invasive and non-invasive mechanical ventilation, a longer duration oxygen support, and longer hospital stay (P < 0.001 for all). The PNAC group had higher respiratory distress syndrome, hemodynamically significant patent ductus arteriosus, necrotizing enterocolitis (NEC) with stage II or higher, surgically treated NEC, late-onset sepsis, metabolic bone disease, and extrauterine growth retardation (EUGR) compared to the non-PNAC group (P < 0.05 for all). In contrast with the non-PNAC group, the PNAC group received a higher maximum dose of amino acids and fat emulsion, more medium/long-chain fatty emulsion, less SMOF, had a longer duration of parenteral nutrition, lower rates of breastfeeding, higher incidence of feeding intolerance (FI), more accumulated days to achieve total enteral nutrition, less accumulated days of total calories up to standard 110 kcal/kg/day and slower velocity of weight growth (P < 0.05 for all). Logistic regression analysis indicated that the maximum dose of amino acids (OR, 5.352; 95% CI, 2.355 to 12.161), EUGR (OR, 2.396; 95% CI, 1.255 to 4.572), FI (OR, 2.581; 95% CI, 1.395 to 4.775), surgically treated NEC (OR, 11.300; 95% CI, 2.127 ~ 60.035), and longer total hospital stay (OR, 1.030; 95% CI, 1.014 to 1.046) were independent risk factors for the development of PNAC. SMOF (OR, 0.358; 95% CI, 0.193 to 0.663) and breastfeeding (OR, 0.297; 95% CI, 0.157 to 0.559) were protective factors for PNAC. Conclusions: PNAC can be reduced by optimizing the management of enteral and parenteral nutrition and reducing gastrointestinal comorbidities in preterm infants.

3 May 2023 in European Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
QYQing Yang
Qing Yang
JKJuan Kong
Juan Kong
RBRui-Miao Bai
Rui-Miao Bai
WYWen-Ting Yu
Wen-Ting Yu
JZJuan Zhang
Juan Zhang
XTXiaomei Tong
Xiaomei Tong
Objective: This study compared the clinical effects of two different lipid emulsions in premature infants with gestational age < 32 weeks (VPI) or birth weight < 1500 g (VLBWI) to provide an evidence-based medicine basis for optimizing intravenous lipid emulsion.Methods: This was a prospective multicenter randomized controlled study. A total of 465 VPIs or VLBWIs, admitted to the neonatal intensive care unit of five tertiary hospitals in China from March 1, 2021 to December 31, 2021, were recruited. All subjects were randomly allocated into two groups, namely, medium-chain triglycerides/long-chain triglycerides (MCT/LCT) group (n = 231) and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) group (n = 234). Clinical features, biochemical indexes, nutrition support therapy, and complications were analyzed and compared between the two groups.Results: No significant differences were found in perinatal data, hospitalization, parenteral and enteral nutrition support between the two groups (P > 0.05). Compared with the MCT/LCT group, the incidence of neonates with a peak value of total bilirubin (TB) > 5 mg/dL (84/231 [36.4% vs. 60/234 [25.6%]), a peak value of direct bilirubin (DB) ≥ 2 mg/dL (26/231 [11.3% vs. 14/234 [6.0%]), a peak value of alkaline phosphatase (ALP) > 900 IU/L (17/231 [7.4% vs. 7/234 [3.0%]), and a peak value of triglycerides (TG) > 3.4 mmol/L (13/231 [5.6% vs. 4/234[1.7%]]) were lower in the SMOF group (P < 0.05). Univariate analysis showed that in the subgroup analysis of < 28 weeks, the incidence of parenteral nutrition-associated cholestasis (PNAC) and metabolic bone disease of prematurity (MBDP) were lower in the SMOF group (P = 0.043 and 0.029, respectively), whereas no significant differences were present in the incidence of PNAC and MBDP between the two groups at > 28 weeks group (P = 0.177 and 0.991, respectively). Multivariate logistic regression analysis revealed that the incidence of PNAC (aRR: 0.38, 95% confidence interval [CI]: 0.20–0.70,P = 0.002) and MBDP (aRR: 0.12, 95% CI: 0.19–0.81,P = 0.029) in the SMOF group were lower than that in the MCT/LCT group. In addition, no significant differences were recorded in the incidence of patent ductus arteriosus, feeding intolerance, necrotizing enterocolitis (Bell’s stage ≥ 2), late-onset sepsis, bronchopulmonary dysplasia, intraventricular hemorrhage, periventricular leukomalacia, retinopathy of prematurity and extrauterine growth retardation between the two groups (P > 0.05).Conclusions: The application of mixed oil emulsion in VPI or VLBWI can reduce the risk of plasma TB > 5 mg/dL, DB ≥ 2 mg/dL, ALP > 900 IU/L, and TG > 3.4 mmol/L during hospitalization. SMOF has better lipid tolerance, reduces the incidence of PNAC and MBDP, and exerts more benefits in preterm infants with gestational age < 28 weeks.

13 April 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
YCYanan Chu
Yanan Chu
QMQingren Meng
Qingren Meng
JYJun Yu
Jun Yu
JZJuan Zhang
Juan Zhang
JCJing Chen
Jing Chen
YKYu Kang
Yu Kang
The vast populations of viruses or bacteriophages in human gut flora remain mysterious. However, poor annotation and abundance estimation remain obstacles to strain-level analysis and clarification of their roles in microbiome ecology and metabolism associated with human health and diseases.

11 September 2023 in Nutrition
Verified
Journal Article
Open access
ZZZhu-Xin Zhang
Zhu-Xin Zhang
QYQing Yang
Qing Yang
WSWei Shen
Wei Shen
SSSi-Yu Song
Si-Yu Song
DYDong Yang
Dong Yang
XLXin-Zhu Lin
Xin-Zhu Lin
The aim of this study was to investigate the effects of soybean, medium-chain triacylglycerols (MCTs), olive oil, and fish oil (SMOF) on short-term clinical outcomes, physical growth, and extrauterine growth retardation (EUGR) in very preterm infants. This was a multicenter retrospective cohort study of very preterm infants hospitalized in neonatal intensive care units at five tertiary hospitals in China between January 2021 and December 2021. According to the type of fat emulsion used in parenteral nutrition (PN), eligible very preterm infants were divided into the MCTs/long-chain triacylglycerol (MCT/LCT) group and SMOF group. Change in weight z-score (weight Δz) between measurements at birth and at 36 wk of postmenstrual age or at discharge, the incidence of EUGR, and short-term clinical outcomes between the two groups were compared and analyzed. We enrolled 409 very preterm infants, including 205 in the MCT/LCT group and 204 in the SMOF group. Univariate analysis showed that infants in the SMOF group had significantly longer duration of invasive mechanical ventilation and PN, longer days to reach total enteral nutrition, and a higher proportion of maximum weight loss than those in MCT/LCT group (all P < 0.05). After adjusting for the confounding variables, multifactorial logistic regression analysis of short-term clinical outcomes showed that SMOF had protective effects on PN-associated cholestasis (odds ratio [OR], 0.470; 95% confidence interval [CI], 0.266-0.831) and metabolic bone disease of prematurity (OR, 0.263; 95% CI, 0.078-0.880). Additionally, SMOF was an independent risk factor for lower weight growth velocity (β = -0.733; 95% CI, -1.452 to -0.015) but had no effect on the incidence of EUGR (OR, 1.567; 95% CI, 0.912 to -2.693). Compared with MCT/LCT, SMOF can reduce the risk for PN-associated cholestasis and metabolic bone disease of prematurity in very preterm infants and has a negative effect on growth velocity but has no effect on the incidence of EUGR.

15 April 2025 in Children
Verified
Journal Article
Open access
PDF file
WHWu Hui
Wu Hui
JZJuan Zhang
Juan Zhang
JZJing Zhang
Jing Zhang
YYYanhong Yu
Yanhong Yu
HZHua Zhang
Hua Zhang
THTongyan Han
Tongyan Han
Background/Objectives: Bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) affect the prognosis of preterm infants, and their coexistence is a risk factor for poor long-term outcomes in very low-birth-weight infants. However, there has been limited in-depth assessment of common and independent risk factors for BPD and ROP within the same cohort. Therefore, we aimed to investigate the risk factors for BPD and ROP in very low-birth-weight infants born at ≤32 weeks of gestation and to explore the interaction between these two diseases. Methods: The participants were divided into four groups: BPD+ROP+, BPD-ROP-, BPD+ROP-, and BPD-ROP+. Gestational age, birth weight, maternal pregnancy complications, birth and postnatal diseases, and treatment conditions were compared among the groups. Subsequently, univariate and multivariate binary logistic regression analyses were conducted to explore the independent risk factors for BPD and ROP. Results: Common risk factors of BPD and ROP included gestational age and prolonged oxygen therapy. The multivariate analysis revealed that gestational age (OR: 4.44; 95% CI: 3–6.57), intubation resuscitation (OR: 2.35; 95% CI: 1.09–5.05), mechanical ventilation duration ≥ 7 days (OR: 1.01; 95% CI: 1.01–1.01), and prolonged total oxygen therapy (OR: 3.13; 95% CI: 1.28–7.64) were independent risk factors for BPD. Additionally, gestational age (OR: 0.66; 95% CI: 0.54–0.81) and prolonged oxygen therapy (OR: 1.02; 95% CI: 1–1.03) were independent risk factors for ROP. Conclusions: The proper control of the duration and concentration of oxygen therapy, along with the minimization of mechanical ventilation time, is crucial for reducing the incidence of both BPD and ROP.

16 December 2019
Verified
Journal Article
Open access
PDF file
MZMengxiang Zhang
Mengxiang Zhang
RDRui Ding
Rui Ding
ZWZuqun Wang
Zuqun Wang
JZJuan Zhang
Juan Zhang
JLJing Liu
Jing Liu
JWJuan Wang
Juan Wang